EyePoint (EYPT) Shares Outstanding (2010 - 2026)
EyePoint (EYPT) reported Shares Outstanding (Entity) of $28.8 million for Q4 2021, up 124.04% on a YoY basis from $12.8 million in Q4 2020, and little changed sequentially from $28.8 million in Q3 2021.
EyePoint (EYPT) Shares Outstanding (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 12 years of Shares Outstanding (Entity) data on file, last reported at $28.8 million in Q4 2021.
- For the quarter ending Q4 2021, Shares Outstanding (Entity) rose 124.04% year-over-year to $28.8 million; the trailing twelve-month figure through Dec 2021 stood at $28.8 million (up 124.04% YoY), and the FY2021 full-year result was $28.8 million, up 124.04% from the prior year.
- Shares Outstanding (Entity) steadied at $28.8 million in Q4 2021, from $28.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $28.8 million in Q3 2021 to a low of $3534.0 in Q2 2017.
- A 5-year average of $12.2 million and a median of $10.7 million in 2019 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) sank 99.9% in 2017 and jumped 130703.62% in 2018, its largest moves.
- Tracing EYPT's Shares Outstanding (Entity) over 5 years: stood at $4.5 million in 2017, then surged by 50.12% to $6.8 million in 2018, then soared by 61.05% to $10.9 million in 2019, then increased by 17.31% to $12.8 million in 2020, then surged by 124.04% to $28.8 million in 2021.
- Business Quant data shows EYPT's Shares Outstanding (Entity) at $28.8 million in Q4 2021, $28.8 million in Q3 2021, and $28.8 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 85,999.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85,999.00 |
| Dec 31, 2025 | 73,251.00 |
| Sep 30, 2025 | 70,168.00 |
| Jun 30, 2025 | 69,926.00 |
| Mar 31, 2025 | 69.77 Mn |
| Dec 31, 2024 | 56,298.00 |
| Sep 30, 2024 | 54.45 Mn |
| Jun 30, 2024 | 53.21 Mn |
| Mar 31, 2024 | 52,913.00 |
| Dec 31, 2023 | 38.90 Mn |
| Sep 30, 2023 | 38.34 Mn |
| Jun 30, 2023 | 37.58 Mn |
| Mar 31, 2023 | 37.49 Mn |
| Dec 31, 2022 | 37.32 Mn |
| Sep 30, 2022 | 37.34 Mn |
| Jun 30, 2022 | 37.32 Mn |
| Mar 31, 2022 | 37.25 Mn |
| Dec 31, 2021 | 28.76 Mn |
| Sep 30, 2021 | 28.77 Mn |
| Jun 30, 2021 | 28.74 Mn |